About | BMJ Digital Health & AI
An open access peer-reviewed journal from BMJ Group, publishing original research, review articles, and opinion pieces in the fields of digital health and artificial intelligence.
An open access peer-reviewed journal from BMJ Group, publishing original research, review articles, and opinion pieces in the fields of digital health and artificial intelligence.
This cross-sectional study uses Medicare Part D claims data to evaluate the share of pharmacies owned by insurers and pharmacy benefit managers (PBMs) and the…
Delve into the nuances of metabolic dysfunction-associated steatohepatitis (MASH) with expert insights on metabolic risk factors, risk stratification, and cutting-edge treatments.
A man in his 70s with myelodysplastic syndrome presented with a painful violaceous eruption on his left lower leg accompanied by low-grade fever and fatigue…
Public health professionals and providers have a role to play in increasing awareness of alcohol’s cancer risk, the U.S. surgeon general said last week. |…
A local physician and hospitalist is engaged in the community through being a sponsored pickleball athlete.
Scientists have identified a gene that causes production of a substance in some citrus that interferes with many medications.
He was a neuropsychiatrist who was studying consciousness when a patient explained what had happened to him, and he realized the phenomenon was real.
TDP43 mislocalization and dysfunction are characteristic of ALS, FTLD, and related neurodegenerative diseases. Dykstra et al. uncover pre- and post-translational mechanisms responsible for regulating cytoplasmic, aggregation-prone…
In the debate over weight loss medications, the FDA appears to have shifted toward the importance of drugs.
Nearly 30% of the funding poured into healthcare startups last year went to companies leveraging artificial intelligence, according to Silicon Valley Bank.